Your session is about to expire
← Back to Search
Device
AcumenTM HPI Software Feature for Noncardiac Surgery
N/A
Waitlist Available
Research Sponsored by Edwards Lifesciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from post non-cardiac surgery to 30 days.
Awards & highlights
Study Summary
This trial looked at whether a protocolized strategy using Hypotension Prediction Index (HPI) software guidance during surgery could help manage intraoperative hemodynamic better in moderate to high-risk surgeries.
Eligible Conditions
- Moderate to High-risk Noncardiac Surgery
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from post non-cardiac surgery to 30 days.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from post non-cardiac surgery to 30 days.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
A Composite of 30-day Moderate-to-severe Perfusion Related Postoperative Complications.
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: HPI ArmExperimental Treatment1 Intervention
AcumenTM HPI Software Feature to guide hemodynamic management in moderate-to-high-risk noncardiac surgery.
Group II: Non-HPI armPlacebo Group1 Intervention
Non-protocolized standard of care management per clinician and provider judgement
Find a Location
Who is running the clinical trial?
Edwards LifesciencesLead Sponsor
180 Previous Clinical Trials
61,983 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger